2024 Q1 Form 10-K Financial Statement

#000143774924009861 Filed on March 28, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $2.815M $1.082M
YoY Change 1372.07% -108.69%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.092M -$29.35M
YoY Change -76.96% -54.25%
Net Earnings / Revenue -38.8% -2713.55%
Basic Earnings Per Share -$0.16 -$4.26
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 6.893M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.644K $2.765K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $4.747M $8.808M
YoY Change -86.67% -78.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $4.579M $7.548M
YoY Change -53.05% -21.33%
SHAREHOLDERS EQUITY
Retained Earnings -$176.6M -$175.5M
YoY Change 20.08%
Common Stock $6.893K $6.893K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$1.092M -$29.35M
YoY Change -76.96% -54.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$121.00 -$639.00
YoY Change 101.67% -118.77%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 $0.00
YoY Change
NET CHANGE
Cash From Operating Activities -$121.00 -$639.00
Cash From Investing Activities
Cash From Financing Activities $0.00 $0.00
Net Change In Cash -$121.00 -$639.00
YoY Change 101.67% -118.77%
FREE CASH FLOW
Cash From Operating Activities -$121.00 -$639.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei No Trading Symbol Flag
NoTradingSymbolFlag
true
CY2023 us-gaap Cash Held In Foreign Currency Acquisition Cost
CashHeldInForeignCurrencyAcquisitionCost
2629 usd
CY2022 us-gaap Cash Held In Foreign Currency Acquisition Cost
CashHeldInForeignCurrencyAcquisitionCost
3235 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133967669 usd
CY2023Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
6.93 pure
CY2023Q4 us-gaap Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets
NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
5.93 pure
CY2023Q4 svvc Net Assets Percentage Of Net Assets
NetAssetsPercentageOfNetAssets
1 pure
CY2022Q4 us-gaap Non Investment Assets Less Non Investment Liabilities Percent Of Net Assets
NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets
-0.311 pure
CY2022Q4 svvc Net Assets Percentage Of Net Assets
NetAssetsPercentageOfNetAssets
1 pure
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2023 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
0.031 pure
CY2019 svvc Investment Company Expense Ratio Before Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioBeforeDeferredTaxExpenseBenefit
-0.0284 pure
CY2023 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2022 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2021 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0 pure
CY2020 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
0.0802 pure
CY2019 svvc Investment Company Expense Ratio Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioDeferredTaxExpenseBenefit
-0.0991 pure
CY2023 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
0.1112 pure
CY2019 svvc Investment Company Expense Ratio Net Of Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfDeferredTaxExpenseBenefit
-0.1275 pure
CY2023 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
-0.0721 pure
CY2022 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.031 pure
CY2019 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction And Deferred Tax Expense Benefit
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionAndDeferredTaxExpenseBenefit
0.028 pure
CY2023 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0813 pure
CY2022 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
-0.2096 pure
CY2021 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0294 pure
CY2020 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0064 pure
CY2019 svvc Investment Company Investment Income Loss Ratio Before Deferred Tax Benefit Percentage
InvestmentCompanyInvestmentIncomeLossRatioBeforeDeferredTaxBenefitPercentage
0.0393 pure
CY2023 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2022 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2021 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2020 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
0 pure
CY2019 svvc Investment Company Deferred Tax Benefit Percentage
InvestmentCompanyDeferredTaxBenefitPercentage
-0.0033 pure
CY2023 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0813 pure
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.2096 pure
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0294 pure
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0064 pure
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.036 pure
CY2023 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.01 pure
CY2022 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.15 pure
CY2021 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.16 pure
CY2020 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.13 pure
CY2019 us-gaap Investment Company Portfolio Turnover
InvestmentCompanyPortfolioTurnover
0.18 pure
CY2011Q2 us-gaap Operations Commenced Date1
OperationsCommencedDate1
2011-04-18
CY2023Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 usd
CY2022 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2022 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2022 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2022 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
814-00830
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-3008946
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
150 Almaden Boulevard, Suite 1250
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95113
CY2023 dei City Area Code
CityAreaCode
408
CY2023 dei Local Phone Number
LocalPhoneNumber
886-7096
CY2023 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
false
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
1000000 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6893056
CY2023 dei Auditor Name
AuditorName
TAIT, WELLER & BAKER LLP
CY2023 dei Auditor Firm
AuditorFirmId
445
CY2023 dei Auditor Location
AuditorLocation
Philadelphia, Pennsylvania
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
133967669 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
142790010 usd
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8733779 usd
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
40121924 usd
CY2023Q4 us-gaap Cash Held In Foreign Currency
CashHeldInForeignCurrency
2765 usd
CY2022Q4 us-gaap Cash Held In Foreign Currency
CashHeldInForeignCurrency
3404 usd
CY2023Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
8161 usd
CY2022Q4 us-gaap Dividend And Interest Receivable
DividendAndInterestReceivable
14463 usd
CY2023Q4 us-gaap Other Assets
OtherAssets
63649 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
64066 usd
CY2023Q4 us-gaap Assets
Assets
8808354 usd
CY2022Q4 us-gaap Assets
Assets
40203857 usd
CY2023Q4 us-gaap Incentive Fee Payable
IncentiveFeePayable
7183782 usd
CY2022Q4 us-gaap Incentive Fee Payable
IncentiveFeePayable
9188187 usd
CY2023Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
13891 usd
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
50000 usd
CY2023Q4 svvc Accrued Consultation Fees
AccruedConsultationFees
43000 usd
CY2022Q4 svvc Accrued Consultation Fees
AccruedConsultationFees
46000 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
307310 usd
CY2022Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
310079 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7547983 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9594266 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6893 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6893 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176770722 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
176770722 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175517244 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-146168024 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7016432
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7016432
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123376
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
123376
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2023Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
8733779 usd
CY2023Q4 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
-7473408 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2022Q4 us-gaap Non Investment Assets Less Non Investment Liabilities
NonInvestmentAssetsLessNonInvestmentLiabilities
-9512333 usd
CY2023 us-gaap Interest Income Foreign Deposits
InterestIncomeForeignDeposits
0 usd
CY2022 us-gaap Interest Income Foreign Deposits
InterestIncomeForeignDeposits
3457 usd
CY2021 us-gaap Interest Income Foreign Deposits
InterestIncomeForeignDeposits
0 usd
CY2023 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
122631 usd
CY2022 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
-10008422 usd
CY2021 svvc Investment Income Expense Total
InvestmentIncomeExpenseTotal
6318695 usd
CY2023 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
455559 usd
CY2022 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
1366496 usd
CY2021 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
2220811 usd
CY2023 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
116785 usd
CY2022 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
118009 usd
CY2021 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
122177 usd
CY2023 us-gaap Custody Fees
CustodyFees
8743 usd
CY2022 us-gaap Custody Fees
CustodyFees
17338 usd
CY2021 us-gaap Custody Fees
CustodyFees
24661 usd
CY2023 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
33296 usd
CY2022 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
38054 usd
CY2021 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
39737 usd
CY2023 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
35300 usd
CY2022 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
33800 usd
CY2021 us-gaap Investment Company Registration Expense
InvestmentCompanyRegistrationExpense
32700 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
398882 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
397138 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
367471 usd
CY2023 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
299958 usd
CY2022 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
60853 usd
CY2021 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
80307 usd
CY2023 us-gaap Trustee Fees
TrusteeFees
43841 usd
CY2022 us-gaap Trustee Fees
TrusteeFees
200000 usd
CY2021 us-gaap Trustee Fees
TrusteeFees
200000 usd
CY2023 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
110336 usd
CY2022 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
118777 usd
CY2021 svvc Investment Company Compliance Expense
InvestmentCompanyComplianceExpense
120487 usd
CY2023 us-gaap Other Noninterest Expense
OtherNoninterestExpense
81068 usd
CY2022 us-gaap Other Noninterest Expense
OtherNoninterestExpense
88580 usd
CY2021 us-gaap Other Noninterest Expense
OtherNoninterestExpense
46907 usd
CY2023 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
1583768 usd
CY2022 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
2439045 usd
CY2021 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
3255258 usd
CY2023 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
2542716 usd
CY2022 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
-0 usd
CY2021 svvc Investment Company Fee Waived Or Reimbursed
InvestmentCompanyFeeWaivedOrReimbursed
-0 usd
CY2023 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
-958948 usd
CY2022 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
2439045 usd
CY2021 svvc Investment Company Expense Income After Reduction Of Fee Waiver And Reimbursement
InvestmentCompanyExpenseIncomeAfterReductionOfFeeWaiverAndReimbursement
3255258 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
1081579 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
-12447467 usd
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
3063437 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
16 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1914 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
27 usd
CY2023 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-7864982 usd
CY2022 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-3129665 usd
CY2021 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
11753065 usd
CY2023 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-22565817 usd
CY2022 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-48567901 usd
CY2021 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-22204246 usd
CY2023 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-30430799 usd
CY2022 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-51697566 usd
CY2021 us-gaap Realized And Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedAndUnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-10451181 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29349220 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-64145033 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7387744 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.26
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.31
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29349220 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-64145033 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7387744 usd
CY2023 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
140000 usd
CY2022 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
9412526 usd
CY2021 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
17350000 usd
CY2023 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
498425 usd
CY2022 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
9937261 usd
CY2021 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
16104357 usd
CY2023 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-598921 usd
CY2022 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
1217769 usd
CY2021 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-1738739 usd
CY2023 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
-6302 usd
CY2022 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
-11471179 usd
CY2021 svvc Increase Decrease In Interest Dividends And Reclaims Receivable
IncreaseDecreaseInInterestDividendsAndReclaimsReceivable
5757044 usd
CY2023 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
0 usd
CY2022 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
-13589 usd
CY2021 us-gaap Increase Decrease In Management Fee Payable
IncreaseDecreaseInManagementFeePayable
13589 usd
CY2023 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
-2004405 usd
CY2022 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
1485273 usd
CY2021 us-gaap Increase Decrease In Due To Affiliates
IncreaseDecreaseInDueToAffiliates
2252215 usd
CY2023 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-417 usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-0 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
38351 usd
CY2023 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-41878 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
198958 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-27671 usd
CY2023 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-7864982 usd
CY2022 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
-3131579 usd
CY2021 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
11753065 usd
CY2023 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-22565817 usd
CY2022 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-48568071 usd
CY2021 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-22204246 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-639 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3404 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-729 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-639 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3404 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-729 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3404 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
729 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2765 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3404 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
CY2023 us-gaap Net Investment Income
NetInvestmentIncome
1081579 usd
CY2022 us-gaap Net Investment Income
NetInvestmentIncome
-12447467 usd
CY2021 us-gaap Net Investment Income
NetInvestmentIncome
3063437 usd
CY2023 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-7864982 usd
CY2022 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-3129665 usd
CY2021 us-gaap Realized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
RealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
11753065 usd
CY2023 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-22565817 usd
CY2022 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-48567901 usd
CY2021 us-gaap Unrealized Gain Loss Investment Derivative And Foreign Currency Transaction Operating After Tax
UnrealizedGainLossInvestmentDerivativeAndForeignCurrencyTransactionOperatingAfterTax
-22204246 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29349220 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-64145033 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7387744 usd
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
-0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-29349220 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-64145033 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-7387744 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
94754624 usd
CY2020Q4 us-gaap Assets Net
AssetsNet
102142368 usd
CY2023Q4 us-gaap Assets Net
AssetsNet
1260371 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30609591 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
94754624 usd
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-0
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-0
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
-0
CY2023 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0
CY2022 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0
CY2021 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
0
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2020Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2023Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2021Q4 us-gaap Shares Outstanding
SharesOutstanding
6893056
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.75
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.82
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.7
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
26.69
CY2023 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.16
CY2022 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
-1.81
CY2021 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.44
CY2020 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.09
CY2019 svvc Investment Company Investment Income Loss Before Deferred Taxes Per Share
InvestmentCompanyInvestmentIncomeLossBeforeDeferredTaxesPerShare
0.9
CY2023 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2022 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2021 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2020 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0
CY2019 svvc Investment Company Deferred Tax Benefit Per Share
InvestmentCompanyDeferredTaxBenefitPerShare
0.08
CY2023 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-1.81
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.44
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.09
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.82
CY2023 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-4.42
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-7.5
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.51
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-2.3
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-12.15
CY2023 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2022 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2021 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
0
CY2020 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
-1.13
CY2019 svvc Investment Company Deferred Tax Expense Per Share
InvestmentCompanyDeferredTaxExpensePerShare
2.34
CY2023 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-4.42
CY2022 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-7.5
CY2021 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-1.51
CY2020 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-3.43
CY2019 svvc Investment Company Gain Loss On Investment Per Share Net Of Deferred Taxes
InvestmentCompanyGainLossOnInvestmentPerShareNetOfDeferredTaxes
-9.81
CY2023 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-4.26
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-9.31
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.07
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-3.34
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-8.99
CY2023 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2022 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2021 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2020 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2019 us-gaap Investment Company Distribution To Shareholders Per Share
InvestmentCompanyDistributionToShareholdersPerShare
-0
CY2023 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2022 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2021 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2020 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0.46
CY2019 svvc Investment Company Antidilutive Effect From Capital Share Transactions Per Share
InvestmentCompanyAntidilutiveEffectFromCapitalShareTransactionsPerShare
0
CY2023Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
0.18
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
4.44
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.75
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
14.82
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
17.7
CY2023Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.3
CY2022Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
0.95
CY2021Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
4.01
CY2020Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
4.47
CY2019Q4 us-gaap Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
6.43
CY2023 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.9595 pure
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.6771 pure
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0722 pure
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1627 pure
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.3368 pure
CY2023 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.6842 pure
CY2022 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.7631 pure
CY2021 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.1029 pure
CY2020 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.3048 pure
CY2019 us-gaap Investment Company Total Return Market Value
InvestmentCompanyTotalReturnMarketValue
-0.4259 pure
CY2023Q4 us-gaap Assets Net
AssetsNet
1300000 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
30600000 usd
CY2021Q4 us-gaap Assets Net
AssetsNet
94800000 usd
CY2020Q4 us-gaap Assets Net
AssetsNet
102100000 usd
CY2019Q4 us-gaap Assets Net
AssetsNet
127100000 usd
CY2023 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.1191 pure
CY2022 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.0411 pure
CY2021 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.0312 pure
CY2020 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.031 pure
CY2019 svvc Investment Company Expense Ratio Net Of Incentive Fee Deduction Deferred Tax Expense Benefit And Fee Waiver
InvestmentCompanyExpenseRatioNetOfIncentiveFeeDeductionDeferredTaxExpenseBenefitAndFeeWaiver
0.028 pure
CY2023 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-0.1099 pure
CY2022 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
-0.2096 pure
CY2021 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.0294 pure
CY2020 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.0064 pure
CY2019 svvc Investment Company Investment Income Loss Ratio Before Voluntary Fee Waiver
InvestmentCompanyInvestmentIncomeLossRatioBeforeVoluntaryFeeWaiver
0.036 pure
CY2019 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0564 pure
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<b>USE OF ESTIMATES.</b> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.
CY2023 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<b>CONCENTRATION OF CREDIT RISK.</b> The Company places its cash and cash equivalents with financial institutions and, at times, cash held in checking accounts <em style="font: inherit;"> may </em>exceed the Federal Deposit Insurance Corporation insured limit.
CY2023Q3 svvc Deferred Compensation Arrangement Percent Of Compensation Deferred
DeferredCompensationArrangementPercentOfCompensationDeferred
0.50 pure
CY2023Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
0 usd
CY2023Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
125233890 usd
CY2023Q4 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-125233890 usd
CY2023Q4 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
133967669 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0698 pure
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3465923 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
4616720 usd
CY2023Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
9161034 usd
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
6960412 usd
CY2023Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
35040442 usd
CY2022Q4 us-gaap Deferred Tax Assets Investments
DeferredTaxAssetsInvestments
28726530 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
47667399 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
40303662 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47667399 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
40303662 usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
12387144 usd
CY2023 svvc Operating Loss Carryforwards Period
OperatingLossCarryforwardsPeriod
P5Y
CY2023 us-gaap Payments For Purchase Of Investment Operating Activity
PaymentsForPurchaseOfInvestmentOperatingActivity
140000 usd
CY2023 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
498425 usd

Files In Submission

Name View Source Status
0001437749-24-009861-index-headers.html Edgar Link pending
0001437749-24-009861-index.html Edgar Link pending
0001437749-24-009861.txt Edgar Link pending
0001437749-24-009861-xbrl.zip Edgar Link pending
a1.jpg Edgar Link pending
bdo.jpg Edgar Link pending
c01.jpg Edgar Link pending
c02.jpg Edgar Link pending
c03.jpg Edgar Link pending
ex_619529.htm Edgar Link pending
ex_619530.htm Edgar Link pending
ex_641264.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fp0081632-2_100.jpg Edgar Link pending
i24.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sccv20231231_10k.htm Edgar Link pending
Show.js Edgar Link pending
sig1.jpg Edgar Link pending
sig2.jpg Edgar Link pending
svvc-20231231.xsd Edgar Link pending
svvc-20231231_def.xml Edgar Link unprocessable
svvc-20231231_lab.xml Edgar Link unprocessable
svvc-20231231_pre.xml Edgar Link unprocessable
sccv20231231_10k_htm.xml Edgar Link completed
svvc-20231231_cal.xml Edgar Link unprocessable